Pregnancy-Related and Perinatal Outcomes in Women With Multiple Sclerosis: A Nationwide Danish Cross-sectional Study.


Journal

Neurology. Clinical practice
ISSN: 2163-0402
Titre abrégé: Neurol Clin Pract
Pays: United States
ID NLM: 101577149

Informations de publication

Date de publication:
Aug 2021
Historique:
received: 19 06 2020
accepted: 04 11 2020
entrez: 6 9 2021
pubmed: 7 9 2021
medline: 7 9 2021
Statut: ppublish

Résumé

To investigate differences in pregnancy-related and perinatal outcomes in women with multiple sclerosis (MS) compared with the general population. We conducted a cross-sectional study including pregnancies from January 1, 1997, to December 31, 2016, to women registered in the Danish Multiple Sclerosis Registry (the study cohort). Pregnancy-related and perinatal outcomes were compared with a randomly selected subcohort of pregnancies from the general population (the comparison cohort) using logistic regression adjusted for possible confounders. In total, 2,930 pregnancies were included in the study cohort and 56,958 pregnancies in the comparison cohort. No differences were found in pregnancy-related complications (preeclampsia/gestational diabetes or placenta complications), emergency caesarean section (c-section), instrumental delivery, low Apgar score, stillbirth, preterm birth, or congenital malformations. Elective c-section (odds ratio [OR] 1.89 [95% confidence interval (CI) 1.65-2.16]), induced delivery (OR 1.15 [95% CI 1.01-1.31]), and being born small for gestational age (SGA) (OR 1.29 [95 %CI 1.04-1.60]) had a higher prevalence in the study cohort, whereas the prevalence of signs indicating asphyxia was lower in the study cohort (OR 0.87 [95% CI 0.78-0.97]) relative to the comparison cohort. We found a higher prevalence of elective c-sections, induced delivery, and infants being SGA among newborns to women with MS, whereas the prevalence of asphyxia was lower in the study cohort. There were no significant differences in severe adverse perinatal outcomes when comparing women with MS and their newborns with those of the general population.

Identifiants

pubmed: 34484927
doi: 10.1212/CPJ.0000000000001035
pii: NEURCLINPRACT2020059972
pmc: PMC8382416
doi:

Types de publication

Journal Article

Langues

eng

Pagination

280-290

Informations de copyright

© 2021 American Academy of Neurology.

Références

Clin Dev Immunol. 2012;2012:985646
pubmed: 22235228
Ann Neurol. 1983 Mar;13(3):227-31
pubmed: 6847134
Pediatr Neonatol. 2014 Feb;55(1):20-7
pubmed: 23850094
Neurology. 2014 Feb 25;82(8):674-80
pubmed: 24463630
Acta Neurol Scand. 2015;132(199):4-10
pubmed: 26046552
Am J Epidemiol. 2019 Jan 1;188(1):57-66
pubmed: 30165561
Neurology. 2018 May 29;90(22):e1954-e1963
pubmed: 29720546
BJOG. 2013 Mar;120(4):479-86; discussion 486
pubmed: 23316937
Scand J Public Health. 2011 Jul;39(7 Suppl):79-82
pubmed: 21775359
Mult Scler. 2010 Aug;16(8):950-5
pubmed: 20542921
Neurology. 2005 Dec 27;65(12):1961-3
pubmed: 16380620
BMJ Open. 2018 Nov 8;8(11):e023531
pubmed: 30413512
Clin Epidemiol. 2016 Oct 25;8:549-552
pubmed: 27822098
Eur J Epidemiol. 2018 Jan;33(1):27-36
pubmed: 29349587
BJOG. 2011 Jun;118(7):790-7
pubmed: 21401856
PLoS One. 2019 Dec 30;14(12):e0227120
pubmed: 31887199
Ann Neurol. 2001 Jul;50(1):121-7
pubmed: 11456302
Mult Scler Relat Disord. 2017 Feb;12:4-8
pubmed: 28283105
PLoS Med. 2019 Sep 24;16(9):e1002913
pubmed: 31550245
Mult Scler Relat Disord. 2017 Oct;17:63-68
pubmed: 29055477
Clin Epidemiol. 2015 Nov 17;7:449-90
pubmed: 26604824
Mult Scler Relat Disord. 2019 Feb;28:172-176
pubmed: 30611102
Ann Med. 2013 Sep;45(5-6):446-54
pubmed: 23768051
Eur J Epidemiol. 2014 Aug;29(8):541-9
pubmed: 24965263
Ulster Med J. 1954 Mar;23(Suppl. 2):1-27
pubmed: 13238437
Lancet Glob Health. 2019 Jul;7(7):e849-e860
pubmed: 31103470
Scand J Public Health. 2011 Jul;39(7 Suppl):91-4
pubmed: 21775362
Ann Neurol. 2011 Jul;70(1):41-50
pubmed: 21710652
J Matern Fetal Neonatal Med. 2018 Feb;31(3):382-387
pubmed: 28139946
Vaccine. 2017 Dec 4;35(48 Pt A):6492-6500
pubmed: 29150054
PLoS One. 2017 Oct 17;12(10):e0186287
pubmed: 29040334
Lancet Neurol. 2010 May;9(5):520-32
pubmed: 20398859
J Perinat Med. 2017 May 24;45(4):455-460
pubmed: 27124670
BMJ Open. 2014 Aug 14;4(8):e005785
pubmed: 25125480
Pediatrics. 1986 Dec;78(6):1148-9
pubmed: 3786042

Auteurs

Johanna Balslev Andersen (JB)

Department of Neurology (JBA, TIK), The Danish Multiple Sclerosis Registry, University of Copenhagen; and Department of Neurology (FS, MM), The Danish Multiple Sclerosis Center, University of Copenhagen, Denmark.

Tine Iskov Kopp (TI)

Department of Neurology (JBA, TIK), The Danish Multiple Sclerosis Registry, University of Copenhagen; and Department of Neurology (FS, MM), The Danish Multiple Sclerosis Center, University of Copenhagen, Denmark.

Finn Sellebjerg (F)

Department of Neurology (JBA, TIK), The Danish Multiple Sclerosis Registry, University of Copenhagen; and Department of Neurology (FS, MM), The Danish Multiple Sclerosis Center, University of Copenhagen, Denmark.

Melinda Magyari (M)

Department of Neurology (JBA, TIK), The Danish Multiple Sclerosis Registry, University of Copenhagen; and Department of Neurology (FS, MM), The Danish Multiple Sclerosis Center, University of Copenhagen, Denmark.

Classifications MeSH